In a landmark development for the field of renewable energy, an international team of researchers has announced a significant breakthrough…
Read More
Breakthrough in Solar Energy Conversion Efficiency Surpasses Theoretical Limits via Singlet Fission and Molybdenum Spin-Flip Emitters
Simulations Plus Forges Strategic Alliances to Pioneer AI-Driven Drug Development
Simulations Plus, a leading provider of advanced modeling and simulation software for drug discovery and development, has announced the establishment…
Read More
Science and armed conflict
Founded in 1921, Science News has a century-long legacy of providing accessible and accurate reporting on scientific advancements, medical breakthroughs,…
Read More
The Physics of Follicles: New Research Uncovers a Surprising Mechanism of Human Hair Growth
A groundbreaking study has overturned decades of established biological understanding, revealing that human hair does not grow by being pushed…
Read More
TWiV 1293: The enemy of your parasite is your friend
This Week in Virology (TWiV) episode 1293, released on February 1, 2026, delved into two groundbreaking scientific discoveries with profound…
Read More
From List Price to Net Price: How Finance Leaders Decode Real Drug Costs
In the intricate landscape of the healthcare industry, the discourse surrounding drug pricing frequently fixates on the list price. Public…
Read More
Lungs Identified as a Primary Site of Blood Production in Humans Challenging Decades of Medical Dogma
For more than a century, the medical community has operated under the fundamental assumption that the bone marrow serves as…
Read More
How digital tools and AI are accelerating drug discovery
The pharmaceutical industry stands at a critical juncture, grappling with escalating costs and protracted timelines in the arduous journey of…
Read More
How Clinical Laboratories Can Prepare for Crisis Events Before They Happen
Clinical laboratories, the silent sentinels of public health, operate at the nexus of patient care and scientific precision. Yet, this…
Read More
Novartis to Acquire Excellergy for Up to $2 Billion to Bolster Next-Generation Anti-IgE Allergy Pipeline
Novartis has entered into a definitive agreement to acquire Excellergy, a privately held biotechnology company specializing in the development of…
Read More